More about

Intrahepatic Tumor

News
December 12, 2019
2 min read
Save

TACE plus Nexavar for unresectable HCC improves progression-free survival

Treatment with transarterial chemoembolization and Nexavar improved progression-free survival compared with transarterial chemoembolization alone in patients with unresectable hepatocellular carcinoma, according to a study published in Gut.